WhiteSwell Medical

About

Funding history · 1 round · $30.0M total

Q&A

What is WhiteSwell Medical's primary focus?

WhiteSwell Medical is dedicated to improving the treatment of acute decompensated heart failure (ADHF), a major cause of repeat hospitalizations.

What type of solution is WhiteSwell Medical developing for ADHF?

The company is developing a minimally invasive, catheter-based approach designed to enhance the natural fluid-removal process of the lymphatic system to more efficiently remove excess interstitial fluid in ADHF patients.

When was WhiteSwell Medical founded?

WhiteSwell Medical was founded in September 2014.

How much funding has WhiteSwell Medical raised in total?

WhiteSwell Medical has raised a total of $30,000,000 USD.

Which investors participated in WhiteSwell Medical's last funding round?

In December 2018, RA Capital Management and InCube Ventures participated in WhiteSwell Medical's funding round.

What is WhiteSwell Medical's current employee count bucket?

WhiteSwell Medical has 11-50 employees.

Where are WhiteSwell Medical's offices located?

WhiteSwell Medical has offices in Shefayim, Israel; Galway, Ireland; and Palo Alto, California, United States.

What is the current product stage of WhiteSwell Medical?

WhiteSwell Medical's product is currently in the R&D stage.

Team · 1

Yaacov Nitzan

Founder · Founder (No longer with the company)

LinkedIn ↗

Sectors & technology

Highlights

Tags